Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Calumet Specialty Products
CLMT
$4.19B
| $7.56M | ﹤0.01% |
210,599
+3,798
| +2% | +$98.3K |
|
2077
Stock Yards Bancorp
SYBT
$2.64B
| $7.56M | ﹤0.01% |
114,052
-2,916
| -2% | -$194K |
|
2078
Progyny
PGNY
$2.02B
| $7.55M | ﹤0.01% |
444,652
-30,894
| -6% | -$662K |
|
2079
Credit Acceptance
CACC
$6.1B
| $7.53M | ﹤0.01% |
17,782
-74
| -0.4% | -$34.9K |
|
2080
VanEck High Yield Muni ETF
HYD
$4.4B
| $7.53M | ﹤0.01% |
150,124
-2,486
| -2% | -$127K |
|
2081
AvePoint
AVPT
$2.85B
| $7.5M | ﹤0.01% |
789,069
+67,514
| +9% | +$760K |
|
2082
Tarsus Pharmaceuticals
TARS
$3.04B
| $7.49M | ﹤0.01% |
106,782
-978
| -0.9% | -$68.3K |
|
2083
Vaalco Energy
EGY
$608M
| $7.47M | ﹤0.01% |
1,178,683
+77,054
| +7% | +$388K |
|
2084
Collegium Pharmaceutical
COLL
$916M
| $7.46M | ﹤0.01% |
225,705
-1,414
| -0.6% | -$59.9K |
|
2085
Vipshop
VIPS
$6.81B
| $7.43M | ﹤0.01% |
472,571
-22,172
| -4% | -$377K |
|
2086
Harmony Biosciences
HRMY
$2.22B
| $7.41M | ﹤0.01% |
264,411
-6
| -0% | -$197 |
|
|
LMUB
2087
iShares Long-Term National Muni Bond ETF
LMUB
$1.6B
| $7.39M | ﹤0.01% |
+148,075
| New | +$7.49M |
|
2088
Enovis
ENOV
$1.5B
| $7.38M | ﹤0.01% |
324,558
-12,338
| -4% | -$292K |
|
2089
G-III Apparel Group
GIII
$1.43B
| $7.38M | ﹤0.01% |
266,471
-7,555
| -3% | -$221K |
|
2090
10x Genomics
TXG
$7.31B
| $7.38M | ﹤0.01% |
347,562
-3,402
| -1% | -$68K |
|
2091
Payoneer
PAYO
$2.42B
| $7.37M | ﹤0.01% |
1,524,961
-78,012
| -5% | -$411K |
|
2092
Center Bancorp
CNOB
$1.79B
| $7.35M | ﹤0.01% |
274,628
-1,831
| -0.7% | -$49.2K |
|
2093
Schwab US Large- Cap ETF
SCHX
$74.9B
| $7.33M | ﹤0.01% |
285,839
-18,890
| -6% | -$507K |
|
2094
Liquidia Corp
LQDA
$6.66B
| $7.32M | ﹤0.01% |
193,920
-4,773
| -2% | -$177K |
|
2095
Triumph Financial Inc
TFIN
$1.87B
| $7.29M | ﹤0.01% |
122,213
-4,788
| -4% | -$299K |
|
2096
Embecta
EMBC
$289M
| $7.28M | ﹤0.01% |
823,787
+10,468
| +1% | +$109K |
|
2097
Dyne Therapeutics
DYN
$4.8B
| $7.28M | ﹤0.01% |
401,616
+48,119
| +14% | +$830K |
|
2098
TriCo Bancshares
TCBK
$1.84B
| $7.28M | ﹤0.01% |
153,127
-2,103
| -1% | -$103K |
|
2099
1st Source
SRCE
$2.13B
| $7.27M | ﹤0.01% |
105,002
-1,700
| -2% | -$115K |
|
2100
ManpowerGroup
MAN
$2.71B
| $7.26M | ﹤0.01% |
246,535
-7,723
| -3% | -$229K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.